Pi Pharma Intelligence and MENA Pharma Forge Strategic Partnership

Amman, Jordan / Detroit, Michigan [ October 1, 2025 ]  Pi Pharma Intelligence, a leading provider of pharmaceutical insights and analytics, and MENA Pharma, a division of MENA Global Group specializing in Pharma consulting, announced a strategic partnership designed to help North American life science and pharmaceutical stakeholders, including biotech clusters, R&D organizations, economic developers, law firms and investment groups to access and expand into the Middle East and North Africa (MENA) region.

By combining Pi Pharma’s advanced analytics and predictive insights with MENA Pharma’s local operational and regulatory expertise, the partnership delivers comprehensive support for market access, licensing agreements, technology transfer, Joint Ventures, and commercialization in MENA.

MENA: A High-Growth Market for North American Life Science stakeholders

The MENA region represents one of the fastest-growing pharmaceutical markets globally, offering significant opportunities for North American Stakeholders:

• Market Size & Growth: 60 billion USD in 2024, projected to surpass 70 billion USD by 2026. It is expected to grow at CAGR of around 7,2%, outpacing the global growth rate.

• Population: Over 400 million with rising healthcare demand.

• High-Demand for advanced Therapeutic Areas: Oncology (9% CAGR in GCC), obesity and diabetes, rare diseases,cardiovascular diseases.

• Government Incentives & Regulatory Advantages:

  • Fast-Track Registration: Accelerated approvals for FDA or EMA approved products, with 60 days review time.

  • Regulatory Exclusivity: First to market protection for innovative medicines, creating competitive advantages.

  • Priority Review: Expedited evaluation for innovative or life-saving therapies.

• Local Manufacturing Encouragement: Support for joint ventures encouraging North American companies to establish technology hubs.

Strategic Benefits for North American Life science stakeholders

This partnership provides North American Life science stakeholders with:

• Actionable Market Intelligence: Real-time updates on molecules, regulatory pathways, pricing, and competitor activity.

• Fast-Track Entry & Regulatory Support: Guidance on securing regulatory exclusivities and leveraging priority review pathways.

• Licensing & Partnership Opportunities: Identification of local partners and partnership models to facilitate smooth market penetration.

• Investment Support: Assistance in establishing connection with the right government entities to facilitate the support.

Executive Insights

“The MENA region is a high-growth, underpenetrated market for U.S. pharma and biotech companies,” said Hazem Yacoub, CEO at Pi Pharma Intelligence. “With regulatory exclusivities, fast-track registration, and substantial government incentives, first movers can gain significant competitive advantages, reduce time-to-market, and capture a high market share. Our partnership with MENA Pharma makes navigating these opportunities seamless and actionable.”

“The Middle East North African pharmaceutical and Life science market is set for rapid growth and transformation, with local companies increasingly taking a larger role”, said William Kaafarani, Managing Director at MENA Pharma. “ For stakeholders, the message is clear: this is the time to enter this market , invest, innovate, and build partnerships that will define the next chapter of growth. The future is bright, and the opportunities are immense both for the stakeholders and the entire range of vendors and collaborators that enable their success”.

About Pi Pharma Intelligence

Pi Pharma Intelligence provides unified market pharmaceutical insights and analytics, enabling strategic decisions on market entry, portfolio management, and competitive positioning. Its flagship platform, Pi Insight, delivers actionable intelligence on molecules, patents, clinical trials, pricing, and regulatory landscapes across MENA.https://www.pipharmaintelligence.com

About MENA Pharma (MENA Global Group)

MENA Pharma, a division of MENA Global Group, specializes in pharmaceutical and Life science consulting across MENA, offering guidance on regulatory compliance, licensing, market entry, and manufacturing strategies to help international Pharma and life science companies succeed in the MENA region.https://menapharma.org